Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02216500

Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

Precision Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Approximately a fourth of children with seizures do not respond adequately to available therapy. Ketogenic therapy has a long history as treatment for intractable epilepsy, but there is no agreement concerning how it works and what is the best way to administer it. This natural history study will collect data pertaining to both questions.

Detailed description

The basis of Ketogenic Therapy is an altered macronutrient intake. It is based on a ratio of fat: protein+carbohydrate in which protein intake is adequate and carbohydrate is minimal. On Ketogenic Therapy, the body metabolizes fat, producing ketones as an energy source for the brain. Induction of ketosis has been shown to correlate with the reduction of seizures observed with Ketogenic Therapy. A major challenge of Ketogenic Therapy in children is that the compounds provided to stop seizure activity are the same compounds provided for growth and development. The altered macronutrient ratio that is the basis of Ketogenic Therapy is also a potential risk factor for dyslipidemia and may adversely affect growth. The investigators will evaluate efficacy of Ketogenic Therapy by assessing seizures and requirements for antiepileptic drugs. The investigators will evaluate adverse effects of Ketogenic Therapy by assessing dyslipidemia and growth. The investigators will foster optimal daily administration of therapy with structured training programs for caregivers.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKetogenic TherapyKetogenic Therapy is based on a ratio of fat: protein+carbohydrate in which protein intake is adequate, fat intake is high, and carbohydrate intake is minimal.

Timeline

Start date
2006-09-01
Primary completion
2030-10-01
Completion
2031-10-01
First posted
2014-08-15
Last updated
2025-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02216500. Inclusion in this directory is not an endorsement.